Chemical and Enzymatic Site Specific PEGylation of hGH: The Stability and in vivo Activity of PEG-N-Terminal-hGH and PEG-Gln141-hGH Conjugates

In Situ Conjugation of Dithiophenol Maleimide Polymers and Oxytocin for Stable and Reversible Polymer–Peptide Conjugates

(2015) Jennifer Collins et al.   BIOCONJUGATE CHEMISTRY

Bioactivity and circulation time of PEGylated NELL-1 in mice and the potential for osteoporosis therapy

(2014) Yulong Zhang et al.   BIOMATERIALS

Phenyl Amide Linker Improves the Pharmacokinetics and Pharmacodynamics of N-Terminally Mono-PEGylated Human Growth Hormone

(2014) Ling Wu et al.   MOLECULAR PHARMACEUTICS

Chemical and Enzymatic Site Specific PEGylation of hGH

(2013) Débora da Silva Freitas et al.   BIOCONJUGATE CHEMISTRY

The impact of PEGylation on protein immunogenicity

(2013) Tal Gefen et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Effects of PEG size on structure, function and stability of PEGylated BSA

(2011) Bitten Plesner et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Biophysical characterisation of GlycoPEGylated recombinant human factor VIIa

(2011) Bitten Plesner et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

A new method to increase selectivity of transglutaminase mediated PEGylation of salmon calcitonin and human growth hormone

(2011) Anna Mero et al.   JOURNAL OF CONTROLLED RELEASE

State of the art in PEGylation: The great versatility achieved after forty years of research

(2011) Gianfranco Pasut et al.   JOURNAL OF CONTROLLED RELEASE

Development of a sustained-release recombinant human growth hormone formulation

(2009) H.H. Kwak et al.   JOURNAL OF CONTROLLED RELEASE

A New PEG−β-Alanine Active Derivative for Releasable Protein Conjugation

(2008) Gianfranco Pasut et al.   BIOCONJUGATE CHEMISTRY

Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase

(2007) Angelo Fontana et al.   ADVANCED DRUG DELIVERY REVIEWS